Davis Polk advised an ad hoc group of prepetition senior secured lenders in connection with the successful chapter 11 restructuring of Expro International Group Holdings Limited and certain…
Davis Polk is advising TiGenix in connection with its entry into an offer and support agreement with Takeda Pharmaceutical Company Limited, pursuant to which Takeda will make a public…
Davis Polk is advising A.P. Moller – Maersk in connection with the disposal of its 50% shareholding in Egyptian Drilling Company to Egyptian General Petroleum Corporation, its joint…
Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…
Davis Polk is advising Nets A/S on certain U.S. aspects of an approximate $5.3 billion takeover offer from Hellman & Friedman. The offer represents a 27% premium to the Nets’ share…
Davis Polk is advising Genuine Parts Company on its approximately $2 billion acquisition of Alliance Automotive Group from private equity funds managed by Blackstone and AAG’s co…
Davis Polk advised Solvay on the signing of a binding agreement with German chemical company BASF for the sale of its Polyamides business. Under the proposed terms of the agreement, the…
Davis Polk is advising A.P. Moller – Maersk A/S in connection with its $7.45 billion disposal of Maersk Oil to Total S.A. Under the agreed terms, Maersk will receive $4.95…
Davis Polk is advising Verisk Analytics, Inc. in connection with its £250 million acquisition of Sequel from HgCapital and other Sequel shareholders. The transaction is expected to close in…
Davis Polk is advising Natura Cosméticos S.A. in connection with the proposed acquisition of The Body Shop group. Following an extensive review of the strategic options for The Body Shop to…